Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Slow Transit Constipation
NCT02526849Phase 2Unknown
- Sponsor
- Jinling Hospital
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of allogeneic fecal microbiota in Slow-transit constipation (STC), sponsored by Jinling Hospital. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Slow-transit constipation (STC)
Beyond the preview
Go deeper on NCT02526849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526849.